BioCritica
Latest round
- Series A
Last raised
- May 2011
Total raised
- $25M
Investors
- 1
About BioCritica
BioCritica, founded in 2011 in Indianapolis, US, specializes in critical care solutions.BioCritica provides a range of innovative medical products specifically designed for critical care settings. These products aim to enhance patient monitoring and management, ensuring improved outcomes in high-stakes medical environments.BioCritica generates revenue through a direct sales model, offering its medical products to healthcare providers. The revenue structure is primarily based on one-time purchases and ongoing service agreements, designed to meet the needs of various healthcare settings.Unfortunately, BioCritica has gone out of business.
Who invested in BioCritica
1 investor across 1 round
See all investors in BioCritica
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 26, 2011
Amount
$25M
Investors
Questions about BioCritica
Who invested in BioCritica?
BioCritica has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioCritica raised?
BioCritica has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioCritica last raise money?
BioCritica's most recent round on record is a Series A, in May 2011.
What does BioCritica do?
BioCritica, founded in 2011 in Indianapolis, US, specializes in critical care solutions.
Where is BioCritica headquartered?
BioCritica is headquartered in Indianapolis, US.
Which VCs invest in companies like BioCritica?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BioCritica's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like BioCritica? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.